SCHEMBL24984732

SCHEMBL24984732

Cc1ccc(Cn2c3ccccc3c3ccccc32)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.54
▸ P2RX4 Q99571 1/20 0.49
▸ CYP19A1 P11511 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CHRNE Q04844 1/20 0.47
▸ GAA P10253 2/20 0.46
▸ LMNA P02545 2/20 0.45
▸ KDM4A O75164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28230447 0.86 MEN1 (0.60) TNFP2RX4CYP19A1ALDH1A1MEN1
SCHEMBL14492825 0.85 CYP19A1 (0.53) P2RX4CYP19A1ALDH1A1MEN1USP2
SCHEMBL30616063 0.82 CHRNE (0.63) CYP19A1ALDH1A1MEN1KMT2ACHRNE
SCHEMBL29093444 0.82 CHRNE (0.63) CYP19A1ALDH1A1MEN1KMT2ACHRNE
SCHEMBL24625817 0.77 CYP19A1 (0.48) P2RX4CYP19A1ALDH1A1MEN1USP2
SCHEMBL14492829 0.77 CYP19A1 (0.61) P2RX4CYP19A1ALDH1A1CYP1A2CYP2C19
SCHEMBL13957031 0.76 P2RX4 (0.66) P2RX4CYP19A1ALDH1A1MEN1KMT2A
SCHEMBL13957030 0.76 P2RX4 (0.66) P2RX4CYP19A1ALDH1A1MEN1KMT2A
SCHEMBL6483528 0.75 MAPT (0.55) ALDH1A1MEN1USP2KMT2AGAA
SCHEMBL12357944 0.75 CYP19A1 (0.70) P2RX4CYP19A1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200102-A1 MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 — — US disclosed
US-20230014550-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014550-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYBA, L1CAM, CHRM1 TNF 1739/4885P2RX4 1375/4885CYP19A1 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback